GlassScriptPhysician profile
Whitney Mascorro
NPI 1033106042
$1,946.79
in general payments reported to CMS, 2019-2025
24 companies · $493 in 2025
The $493 reported for 2025 was more than what 80% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $113 · 2020: $117 · 2021: $369 · 2022: $275 · 2023: $382 · 2024: $197 · 2025: $493.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,073.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,073.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $327.36 | 2023-2025 | Veozah, Myrbetriq |
| Evofem Biosciences, INC. | $173.00 | 2021-2022 | |
| Abbvie INC. | $170.87 | 2019-2024 | |
| Mayne Pharma Commercial LLC | $169.05 | 2023-2025 | |
| Sumitomo Pharma America, INC. | $151.36 | 2023-2025 | Myfembree, Gemtesa |
| Gynesonics, INC. | $135.28 | 2022 | |
| Pfizer INC. | $132.39 | 2021-2023 | |
| Therapeuticsmd, INC. | $114.45 | 2019-2021 | |
| Novo Nordisk INC | $83.05 | 2021-2025 | Wegovy |
| Hologic Sales and Service, LLC | $72.18 | 2025 | Myosure Tissue Removal Device |
| Biogen, INC. | $55.04 | 2025 | Zurzuvae |
| Exeltis, USA INC. | $49.04 | 2021-2025 | Slynd |
| Ethicon US, LLC | $38.85 | 2022-2023 | Megadyne |
| Coopersurgical, INC. | $36.50 | 2020 | |
| Amgen INC. | $36.23 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $35.44 | 2020-2021 | |
| Organon LLC | $32.63 | 2021-2024 | |
| Mission Pharmacal Company | $31.97 | 2024 | Citranatal Medley |
| Minerva Surgical, INC | $24.41 | 2023 | |
| Shield Therapeutics INC | $19.65 | 2023 | |
| Myovant Sciences INC. | $16.93 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.28 | 2021 | |
| Avion Pharmaceuticals | $13.59 | 2020 | |
| Lupin INC. | $12.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Whitney Mascorro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.